Procter & Gamble Health posts 30% profit growth for FY26
The company closed the year with ₹327 crore in profit as Q4 momentum accelerated. Shareholders will receive a total dividend of ₹205 per share.
What's new
- FY26 sales reached ₹1,385 crore, up 16% year-on-year.
- Q4 revenue rose 20% to ₹365 crore, with net profit jumping 55% to ₹95 crore.
- The board declared a final dividend of ₹45 per share, totaling ₹205 for the year.
Why this matters
The results confirm a strong finish to the year, with Q4 growth outpacing the annual average. While the numbers were largely anticipated, the double-digit profit expansion demonstrates the effectiveness of recent brand investments.
What we're watching
- Whether the Q4 growth rate of 20% in revenue is sustainable into FY27.
- The impact of further product innovations on operating margins.
- Any shifts in consumer demand patterns in the coming quarters.
The full read
Procter & Gamble Health closed FY26 with ₹1,385 crore in sales and ₹327 crore in profit after tax. These figures represent growth of 16% and 30% respectively over the prior year. The momentum was particularly visible in the final quarter, where revenue climbed 20% to ₹365 crore and net profit jumped 55% to ₹95 crore. The board has recommended a final dividend of ₹45 per share, which brings the total annual payout to ₹205 per share. While these audited results confirm the company's trajectory, they were largely anticipated by the market following earlier disclosures. The primary takeaway is the acceleration in profitability during the final three months of the year, which suggests that recent brand investments and product launches are gaining traction with consumers. The company enters the new fiscal year with a clear trend of expanding margins.
Questions answered
- What was the total dividend payout for FY26?
- The total dividend for the year is ₹205 per share. This includes an interim dividend of ₹160 paid earlier and a final dividend of ₹45 per share.
- How did the fourth quarter compare to the full-year performance?
- Q4 performance was stronger than the annual trend. Revenue grew 20% in the quarter compared to 16% for the full year, while net profit surged 55% against a 30% annual increase.
- What factors contributed to the Q4 performance?
- Management attributes the growth to strong consumer response to new product innovations and ongoing brand investments.
- Are these results a surprise to the market?
- No. The filing serves as confirmation of previously disclosed unaudited figures.